Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1) is a nuclear protein that plays a critical role in the DNA damage response (DDR) by serving as an adaptor that interacts with the heterotrimeric RAD9-HUS1-RAD1 (9-1-1) DNA clamp complex. RHNO1 promotes activation of the ATR-CHK1 checkpoint in response to replication stress and is necessary for efficient repair of double-strand DNA breaks via microhomology-mediated end joining (MMEJ) and homologous recombination (HR). It accumulates during mitosis, where it is phosphorylated by Polo-like kinase 1 (PLK1) and recruits polymerase theta (POLQ) for mitotic DNA repair. The N-terminal APSES DNA-binding domain of RHNO1 mediates its interaction with the 9-1-1 complex. Overexpression or dysregulation of RHNO1 is associated with enhanced survival and chemoresistance of cancer cells, and may represent a promising target for therapeutic intervention in tumors that depend on heightened DDR signaling.
Drugs targeting the ATR-CHK1 pathway may indirectly impact RHNO1 function by disrupting checkpoint activation and DNA damage repair. There is interest in targeting the RHNO1-9-1-1 interaction to down-regulate the DNA damage checkpoint in cancer therapy.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1).